呼吸道感染流感嗜血杆菌生物学分型及耐药基因研究

摘要
图/表
参考文献(15)
相关文章 (15)

全文: PDF (0 KB) HTML (44 KB)
输出: BibTeX | EndNote (RIS)

摘要目的调查Hi的阳性率、生物学分型和耐药情况。方法2015年1月～2016年12月从惠东县人民医院门诊及住院患者呼吸道标本中分离流感嗜血杆菌共200株，用法国梅里埃系统API NH进行鉴定确认生物型，并同时检测β-内酰胺酶。采用K-B纸片扩散法对12种抗生素进行药敏实验。根据药敏结果，对于有对β-内酰胺酶类抗生素产生耐药性的Ⅰ、Ⅱ、Ⅲ、Ⅳ型别，PCR检测TEM-1和ROB-1基因。统计不同生物型的β-内酰胺酶、抗生素耐药率、基因检出率。结果共检出Ⅰ～Ⅴ型、Ⅷ型6种生物型，其中比例最高的是Ⅲ型，占38%；其次是Ⅱ型，占25%。Ⅴ型、Ⅷ型未见对12种抗生素耐药。Ⅳ型对于抗生素的耐药率最高，对于氨苄西林、头孢呋辛、头孢他定、氨曲南、阿奇霉素均产生耐药。35.16%的菌株对氨苄西林等β-内酰胺类抗生素呈现耐药性。34.04%菌株产生β-内酰胺酶，TEM-1阳性率为54.26%，ROB-1为6.38%。结论惠东县人民医院收集的呼吸道感染流感嗜血杆菌的生物型有Ⅰ～Ⅴ型、Ⅷ型6种，以Ⅱ型、Ⅲ型为主，Ⅳ型亦占一定比例。Ⅴ型、Ⅷ型未见对12种抗生素耐药。Ⅳ型对于抗生素的耐药率最高。对氨苄西林等β-内酰胺类抗生素，耐药机制以质粒介导的TEM产β-内酰胺酶型为主，少数为ROB-1介导。关注Hi致病生物型的流行情况，对于合理选择抗生素具有重要意义。

	服务

	把本文推荐给朋友
	加入我的书架
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章
	周世娟
	刘运香
	林华杰
	余进胜
	徐洁玲

关键词 ：流感嗜血杆菌, 生物型, 耐药, 基因

Abstract：Objective To investigate the positive rate,the biological type and the drug resistance of Haemophilus influenzae.Methods 200 strains of Haemophilus influenzae were separated from outpatient and hospitalized patients of Huidong County People′s Hospital from January 2015 to December 2016.Biological types and beta lactamase were identified with API NH of France bioMerieux identification system.The drug sensitivity test of 12 antibiotics was performed by K-B disk diffusion method.According to the results of drug sensitivity,TEM-1 and ROB-1 gene of the strains ofⅠ,Ⅱ,Ⅲ,andⅣbiotypes were detected by PCR.Results There were 6 biotypes,which were typeⅠ-Ⅴ,andⅧtype.The highest proportion was typeⅢ (38%)and typeⅡ (25%).TypeⅤ,typeⅧwas sensitive to 12 antibiotics.TypeⅣhad the highest antibiotic resistance rate of Ampicillin,Cefuroxime,Ceftazidime,Aztreonam and Azithromycin.35.16% of the strains showed resistance to Ampicillin and other beta lactam antibiotics.34.04%strains produced beta lactam. The positive rate of TEM-1 gene was 54.26%,while the positive rate of ROB-1 gene was 6.38%.Conclusion There were 6 biological type of Haemophilus influenzae in Huidong County People′s Hospital.TypeⅡ and typeⅢ were the dominant biotypes,andⅣtype also shared a certainproportion.TypeⅤ,typeⅧwassensitiveto12antibiotics.Thebiological typewhichwashighestresistancetoantibiotics would be typeⅣ.The production of beta lactamase is mainly mediated by TEM,and just a few strains mediated by ROB-1.To pay attention to the epidemic situation of Hi is of great significance for the selection of antibiotics.

Key words： Haemophilus influenza Biological type Drug resistance Gene

基金资助:广东省惠州市科技计划项目（20160806）

引用本文:

周世娟;刘运香;林华杰;余进胜;徐洁玲. 呼吸道感染流感嗜血杆菌生物学分型及耐药基因研究[J]. 中国当代医药, 2017, 24(4): 162-165.
ZHOU Shi-juan;LIU Yun-xiang;LIN Hua-jie;YU Jin-sheng;XU Jie-ling. Study on the biological typing and drug resistance genes of Haemophilus influenzae. 中国当代医药, 2017, 24(4): 162-165.

链接本文:

http://dangdaiyiyao.com/CN/ 或 http://dangdaiyiyao.com/CN/Y2017/V24/I4/162

[1]	王云桥，厉小玉，陈刚，等.儿童感染流感嗜血杆菌分离培养与耐药性分析[J].中国当代医药，2013，20（32）：108-109.
[2]	陈紫桃，易燕桃，李迪，等.小儿社区获得性肺炎的致病菌分布及耐药性分析[J].中国当代医药，2014，21（15）：107-109.
[3]	隆丰厚，艾文卫，唐孝志，等.新邵地区成人呼吸道感染流感嗜血杆菌生物学分型及耐药基因研究[J].实用预防医学，2014，21（1）：35-38.
[4]	江秀爱，赵自云，姜蓓，等.呼吸道嗜血杆菌属的生物学分型及耐药性分析[J].国际检验医学杂志，2015，36（19）：2840-2841.
[5]	王运中，季伟，陶云珍，等.儿童呼吸道感染流感嗜血杆菌的生物学分型及耐药性[J].江苏医药，2012，38（7）：777-779.
[6]	田磊，张真，陈中举，等.流感嗜血杆菌的分型研究[J].中国微生态学杂志，2014，26（3）：290-294.
[7]	孙丹丹，刘晓华.儿童急性呼吸道感染流感嗜血杆菌的分离鉴定与药敏分析研究[J].中国医药指南，2014，12（14）：165-166.
[8]	Chong L，Xia Y，Qian L，et al.Antibiotic resistance and molecular epidemiology of the beta-lactamase-producing Haemophilus influenzae isolated in Chongqing，China[J].APMIS，2012，120（11）：926-934.
[9]	Takakura M，Fukuda Y，Nomura N，et al.Antibacterial susceptibility surveillance of Haemophilus influenzae isolated from pediatric patients in Gifu and Aichi prefectures（2009-2010）[J].Jpn J Antibiot，2012，65（5）：305-321.
[10]	Resman F，Ristovski M，Forsgren A，et al.Increase of βlactam-resistant invasive Haemophilus influenzae in Sweden，1997 to 2010[J].Antimicrob Agents Chemother，2012，56（8）：4408-4415.
[11]	Kuvat N，Nazik H，Berkiten R，et al.TEM-1 and ROB-1 presence and antimicrobial resistance in Haemophilus influenzae strains，Istanbul，Turkey[J].Southeast Asian J Trop Med Public Health，2015，46（2）：254-261.
[12]	Sndergaard A，Nrskov-Lauritsen N.Contribution of PBP3 substitutions and TEM-1，TEM-15，and ROB-1 Beta-lactamases to Cefotaxime resistance in Haemophilus influenzae and Haemophilus parainfluenzae[J].Microb Drug Resist，2015，22（4）：247-252.
[13]	Sndergaard A，Lund M，Nrskov-Lauritsen N.TEM-1-encoding small plasmids impose dissimilar fitness costs on HaemophilusinfluenzaeandHaemophilusparainfluenzae[J]. Microbiology，2015，161（12）：2310-2315.
[14]	Baturin VA，Shchetinin EV，Malykhin FT.Regional specifics of microbial landscape in outpatients with lower respiratory tract infections[J].Int J Risk Saf Med，2015，27：S61-S62.
[15]	Giufrè M，Daprai L，Cardines R，et al.Carriage of Haemophilus influenzae in the oropharynx of young children and molecular epidemiology of the isolates after fifteen years of H.influenzae type b vaccination in Italy[J].Vaccine，2015，33（46）：6227-6234.